1. Home
  2. HUMAW vs SPMC Comparison

HUMAW vs SPMC Comparison

Compare HUMAW & SPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • SPMC
  • Stock Information
  • Founded
  • HUMAW 2004
  • SPMC 2022
  • Country
  • HUMAW United States
  • SPMC United States
  • Employees
  • HUMAW 220
  • SPMC N/A
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • SPMC
  • Sector
  • HUMAW Health Care
  • SPMC
  • Exchange
  • HUMAW Nasdaq
  • SPMC NYSE
  • Market Cap
  • HUMAW N/A
  • SPMC N/A
  • IPO Year
  • HUMAW N/A
  • SPMC N/A
  • Fundamental
  • Price
  • HUMAW $0.48
  • SPMC $18.19
  • Analyst Decision
  • HUMAW
  • SPMC Strong Buy
  • Analyst Count
  • HUMAW 0
  • SPMC 2
  • Target Price
  • HUMAW N/A
  • SPMC $21.75
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • SPMC 27.0K
  • Earning Date
  • HUMAW 03-21-2025
  • SPMC 08-14-2025
  • Dividend Yield
  • HUMAW N/A
  • SPMC 11.68%
  • EPS Growth
  • HUMAW N/A
  • SPMC N/A
  • EPS
  • HUMAW N/A
  • SPMC N/A
  • Revenue
  • HUMAW N/A
  • SPMC $84,324,319.00
  • Revenue This Year
  • HUMAW N/A
  • SPMC $11.51
  • Revenue Next Year
  • HUMAW N/A
  • SPMC $10.47
  • P/E Ratio
  • HUMAW N/A
  • SPMC $17.50
  • Revenue Growth
  • HUMAW N/A
  • SPMC 81.83
  • 52 Week Low
  • HUMAW $1.18
  • SPMC $16.26
  • 52 Week High
  • HUMAW $1.34
  • SPMC $22.30
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • SPMC N/A
  • Support Level
  • HUMAW N/A
  • SPMC N/A
  • Resistance Level
  • HUMAW N/A
  • SPMC N/A
  • Average True Range (ATR)
  • HUMAW 0.00
  • SPMC 0.00
  • MACD
  • HUMAW 0.00
  • SPMC 0.00
  • Stochastic Oscillator
  • HUMAW 0.00
  • SPMC 0.00

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: